MIF-1 is a tripeptide containing aromatic and hydrophobic residues arranged to influence local conformational stability. The motif supports studies of peptide-protein interactions, solvent-induced folding, and enzymatic processing. Researchers use it to explore compact structural states and residue-dependent binding. Its short length enables high-resolution analytical characterization.
CAT No: R2092
CAS No:2002-44-0
Synonyms/Alias:H-Pro-Leu-Gly-NH2;Melanocyte-Stimulating Hormone Release-Inhibiting Factor;Melanocyte-Stimulating Hormone Release-Inhibiting Hormone;Melanostatin;MIF-1;MIF-I;MSH Release-Inhibiting Factor;MSH Release-Inhibiting Hormone;Oxytocin (7-9);Pro-Leu-Gly-NH2;Pro-Leu-Glyamide;Prol Leu Gly NH2;Prol-Leu-Gly-NH2;Prolyl Leucyl Glycinamide;Prolyl-Leucyl-Glycinamide;Prolylleucylglycinamide
MIF-1 (Melanocyte-Inhibiting Factor 1) is a tripeptide compound composed of proline, leucine, and glycine, recognized for its unique biochemical properties and its role in neuropeptide research. As a naturally occurring peptide, it has garnered significant attention due to its modulatory effects on central nervous system signaling and its influence on neuroendocrine pathways. MIF-1 is particularly notable for its interaction with peptide receptors and its involvement in the regulation of neurotransmitter systems, making it a valuable tool in neuropharmacology and peptide functional studies. Its small size and defined sequence also render it a useful model for investigating peptide structure-activity relationships and receptor binding dynamics.
Neuropharmacology research: MIF-1 serves as a key probe in the study of neuromodulation and peptide signaling mechanisms within the brain. Researchers utilize it to investigate the modulation of dopaminergic and opioid systems, as well as its effects on neuropeptide Y and melanocyte-stimulating hormone pathways. By applying MIF-1 in experimental models, scientists can dissect the peptide's influence on synaptic transmission, receptor sensitivity, and neural plasticity, thereby advancing the understanding of peptide-mediated neuronal regulation.
Peptide receptor characterization: The compound is frequently employed in receptor binding assays and structure-activity relationship studies aimed at elucidating the molecular interactions between neuropeptides and their cognate receptors. Its defined sequence and biological activity make it a suitable ligand for mapping receptor subtypes and determining binding affinities. Such studies contribute to the identification of novel peptide receptors and the characterization of their pharmacological profiles, supporting the development of selective agonists or antagonists for research purposes.
Peptide synthesis validation: MIF-1 is often used as a reference standard or control in peptide synthesis laboratories due to its well-characterized sequence and established chromatographic properties. Synthetic chemists and analytical scientists rely on it to validate peptide coupling strategies, optimize purification protocols, and benchmark analytical methods such as HPLC and mass spectrometry. Its use in these contexts ensures the reliability and reproducibility of peptide production workflows, facilitating the development of novel peptide analogs.
Behavioral neuroscience assays: In experimental behavioral paradigms, the tripeptide is utilized to explore its effects on learning, memory, and motivational processes in animal models. By administering MIF-1 and monitoring behavioral outcomes, researchers can investigate the role of small neuropeptides in cognitive function and neurobehavioral adaptation. These studies provide insight into the molecular underpinnings of behavior and support the identification of peptide-based modulators of neurobiological processes.
Peptidase substrate studies: Owing to its simple structure and biological relevance, MIF-1 is commonly used as a substrate in enzymatic assays designed to characterize peptidase activity. Enzyme kinetics experiments employing this peptide help elucidate the specificity and catalytic mechanisms of various peptidases involved in neuropeptide processing. The data generated from such studies enhance the understanding of peptide turnover in neural tissues and inform the development of enzyme inhibitors or modulators for basic research applications.
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
5. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More